BIOMERICA INC 10-K

ITEM 5. MARKET FOR COMMON EQUITY AND RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES On August 26, 2016, the Company’s common stock became listed and began trading on the Nasdaq Capital Market stock exchange where it trades under the symbol BMRA. Previous to that date, the Company’s stock traded on the OTC Bulletin Board. As of August 29, 2022, the number of holders of record of Biomerica's common stock was approximately 800, excluding stock held in street name. The number of record holders does not bear any relationship to the number of beneficial owners of the common stock as most of the Company’s common stock is held in street name at securities brokerage firms. The Company has not paid any cash dividends on its common stock in the past and does not plan to pay any cash dividends on its common stock in the foreseeable future. The Company's Board of Directors (“Board”) intends, for the foreseeable future, to retain any earnings to finance the continued operation and expansion of the Company's business. We did not sell any unregistered equity securities during the year ended May 31, 2022. We did not purchase any of our shares of common stock or other securities during our fiscal year ended May 31, 2022. The table below provides information relating to our equity compensation plans as of May 31, 2022: Securities Remaining Available for Future Issuance Under Compensation Plans (Excluding those Reflected in Second Column) Securities Plan Category Number of Securities to be Issued Upon Exercise of Outstanding Options Compensation Plans Weighted-Average Exercise Price of Outstanding Options Equity compensation Plans approved by Securities holders 2,321,616 $3.72 102,801 ITEM 6. RESERVED Not required.